118 results on '"Fessel, W Jeffrey"'
Search Results
2. Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms
3. Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno-THEO on a Large Clinical Database
4. Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with past Treatment
5. HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance
6. Therapy with Efavirenz Plus Indinavir in Patients with Extensive Prior Nucleoside Reverse-Transcriptase Inhibitor Experience: A Randomized, Double-Blind, Placebo-Controlled Trial
7. Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
8. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml
9. Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
10. Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factor
11. Association of osteonecrosis and osteoporosis in HIV-1-infected patients
12. Impaired neurocognition in HIV-infected patients: antecedents and treatment
13. Virologic efficacy of boosted double versus boosted single protease inhibitor therapy
14. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
15. Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors
16. Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone disease
17. High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistribution
18. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic: Mycobacterium avium complex disease in patients with HIV infection
19. Viral Load and Response to Treatment of HIV
20. Early Treatment of HIV Infection
21. Cryptococcal Meningitis After Unusual Exposures To Birds
22. Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens.
23. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
24. The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment
25. Response to Therapy in Antiretroviral Therapy--Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor--Associated Transmitted Drug Resistance.
26. Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes.
27. Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation.
28. Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors.
29. Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms.
30. Biomarker discovery using targeted maximum-likelihood estimation: Application to the treatment of antiretroviral-resistant HIV infection.
31. HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance.
32. Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse-Transcriptase Inhibitor Experience: A Randomized, Double-Blind, Placebo-Controlled Trial.
33. Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy.
34. A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis.
35. Once Weekly Azithromycin Therapy for Prevention of Mycobacterium avium Complex Infection in Patients with AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial.
36. Human Immunodeficiency Virus (HIV) RNA in Plasma as the Preferred Target for Therapy in Patients with HIV Infection: A Critique.
37. Letters and Corrections.
38. PERIPHERAL VASOCONSTRICTION INDUCED BY EMOTIONAL STRESS IN RATS.
39. PSYCHOSIS AND SYSTEMIC LUPUS ERYTHEMATOSUS—A Review of the Literature and Case Reports
40. Su1415 The Tolerability of Sof/VEL for 12 Weeks in >1000 Patients Treated in the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies: An Integrated Safety Analysis.
41. Invited Commentary: Early Symptoms of Human Immunodeficiency Virus Infection.
42. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
43. Mutation Patterns and Structural Correlates in Human Immunodeficiency VIrus Type 1 Protease following Different Protease Inhibitor Treatments.
44. Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral-Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations.
45. Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.
46. Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
47. Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.
48. Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.
49. HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.
50. HIV-1 protease mutations and protease inhibitor cross-resistance.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.